Enterocolitis, Necrotizing: Clinical Trials

3 trials for Enterocolitis, Necrotizing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3
Phase 12Terminated 2

Follow Enterocolitis, Necrotizing: new trials by email Literature Review of Enterocolitis, Necrotizing trials Research Report on Enterocolitis, Necrotizing

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SMOFlipid to Lessen the Severity of Neonatal Cholestasis
SMOFlipid - Cholestasis, Jaundice, Obstructive
Phase 1 / Phase 2TerminatedUniversity of Florida22016-05-012017-04-17
Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome
Phase 1 / Phase 2TerminatedAlberta Children's Hospital132012-01-012014-12-23
Probiotics Reduce Incidence of Necrotizing Enterocolitis for Very Low Birth Weight Infants
infloran - Enterocolitis, Necrotizing
Phase 2TerminatedChina Medical University Hospital2172005-02-012007-10-05

Narrower conditions

Cholestasis (1)  ·  Gastroschisis (1)  ·  Hyperphagia (1)  ·  Infant Nutrition Disorders (1)  ·  Intestinal Atresia (1)  ·  Intestinal Failure (1)  ·  Jaundice, Obstructive (1)  ·  Malnutrition (1)  ·  Short Bowel Syndrome (1)

Broader conditions

Digestive System Diseases (3)  ·  Enterocolitis (3)  ·  Gastroenteritis (3)  ·  Gastrointestinal Diseases (3)  ·  Intestinal Diseases (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Abnormalities (1)  ·  Hernia (1)  ·  Hernia, Abdominal (1)  ·  Hyperbilirubinemia (1)

Interventions

Glucagon-Like Peptide 2 (1)  ·  Parenteral Nutrition (1)  ·  SMOFlipid (1)

Sponsors

Alberta Children's Hospital (1)  ·  China Medical University Hospital (1)  ·  University of Florida (1)

Countries

Canada (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

David Sigalet, MD PhD (1)  ·  Josef Neu, MD (1)

Results publications

PMID 18829790